China Healthcare Weekly (Feb.19) - VBP on Biosimilar Drugs, Poor Performance of Healthcare Sector
This article analyzed the new document about VBP for biosimilar drugs, diabetes drugs market, support devices market in interventional fields,...
263 Views
China Healthcare Weekly (Nov.6)
This article summarized the new healthcare policy released in China, major industry viewpoints, company news and capital markets review for the...
207 Views
Shanghai/Shenzhen Connect Ideas: Stalled Flows Ahead of Golden Week (2019-10-04)
In our weekly Shanghai/Shenzhen Connect Ideas series, we aim to help our investors understand the flow of northbound trades via the Shanghai and...
430 Views
Shanghai/Shenzhen Connect Ideas: Technologies, Porks and Hard Liquors (2019-05-17)
In our weekly Shanghai/Shenzhen Connect Ideas series, we aim to help our investors understand the flow of northbound trades via the Shanghai and...
554 Views
Europe M&A: Huadong's Offer for Sinclair Looks a Done Deal
After confirmation of discussions of the merger back in early July, Sinclair Pharma (SPH LN) announced it has entered into an Offer Agreement with...
455 Views